Implementation of MALDI-TOF mass spectrometry in microbiology laboratories: what changes for clinicians?

Authors

  • É. Carbonnelle hôpital Européen Georges Pompidou
  • X. Nassif Université Paris Descartes

DOI:

https://doi.org/10.1007/s13546-012-0480-y

Keywords:

Pulmonary embolism, Cardiogenic shock, Right ventricle, Pathophysiology, Mortality

Abstract

Mass spectrometry (MS) has emerged as a particularly powerful tool for analysis and characterization of proteins in research for twenty years. More recently, matrix assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF-MS) has been introduced in clinical laboratories for routine identification. This method is reliable and safe for the identification of bacteria, yeasts, filamentous fungi, and dermatophytes isolated from clinical samples by intact cell mass spectrometry or directly from positive blood culture or urines. Other applications are currently in development, including bacterial typing, detection of antibiotic resistance, and identification of virulent strains.

Published

2012-04-18

How to Cite

Carbonnelle, É., & Nassif, X. (2012). Implementation of MALDI-TOF mass spectrometry in microbiology laboratories: what changes for clinicians?. Médecine Intensive Réanimation, 21(3), 351–361. https://doi.org/10.1007/s13546-012-0480-y

Issue

Section

Technical Note

Similar Articles

You may also start an advanced similarity search for this article.